1.31

0.77% 0.01

Pre-market: 1.32 0.01 +0.76%

Heron Therapeutics Inc (HRTX)

Overview News Price History Option Chain Financials Why HRTX Down? Discussions Forecast Stock Split

Heron Therapeutics Inc stock is traded at $1.31, with a volume of 1.70M. It is up +0.77% in the last 24 hours and up +18.02% over the past month. Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Previous Close:

$1.30

Open:

$1.29

24h Volume:

1.70M

Relative Volume:

0.95

Market Cap:

$240.20M

Revenue:

$137.74M

Net Income/Loss:

$-27.97M

P/E Ratio:

-8.1875

EPS:

-0.16

Net Cash Flow:

$-9.61M

1W Performance:

+12.93%

1M Performance:

+18.02%

6M Performance:

-34.50%

1Y Performance:

-23.84%

1-Day Range:

$1.2616

$1.3382

1-Week Range:

$1.10

$1.3382

52-Week Range:

$0.9999

$2.68

Heron Therapeutics Inc Stock (HRTX) Company Profile

Name

Heron Therapeutics Inc

Sector

Healthcare (1133)

Industry

Biotechnology (634)

Phone

(858) 251-4400

Address

4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA

Employee

122

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

HRTX's Discussions on Twitter

Compare HRTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HRTX Heron Therapeutics Inc	1.31	240.20M	137.74M	-27.97M	-9.61M	-0.16
VRTX Vertex Pharmaceuticals Inc	455.48	116.04B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	718.36	75.97B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	458.12	61.48B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	901.17	56.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	204.00	43.73B	447.02M	-1.18B	-906.14M	-6.1812

Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-09-25	Initiated	H.C. Wainwright	Buy
Jun-13-24	Initiated	Rodman & Renshaw	Buy
Apr-23-24	Initiated	CapitalOne	Overweight
Mar-13-24	Reiterated	Needham	Buy
May-27-20	Initiated	Guggenheim	Buy
Feb-20-20	Reiterated	Needham	Buy
Jan-16-19	Reiterated	Needham	Buy
Apr-05-18	Initiated	Evercore ISI	Outperform
Mar-19-18	Reiterated	Mizuho	Buy
Mar-01-18	Reiterated	Needham	Buy
Jan-03-18	Initiated	Leerink Partners	Outperform
Sep-27-17	Initiated	Northland Capital	Outperform
Feb-27-17	Initiated	Needham	Buy
Oct-26-16	Initiated	Aegis Capital	Buy
Sep-06-16	Resumed	Lake Street	Buy
May-03-16	Initiated	Cantor Fitzgerald	Buy
Dec-10-15	Initiated	Lake Street	Buy
Sep-23-15	Reiterated	Leerink Partners	Outperform
Sep-02-15	Initiated	BofA/Merrill	Buy
Aug-03-15	Reiterated	Brean Capital	Buy
Jun-30-15	Reiterated	JMP Securities	Mkt Outperform
Jun-19-15	Reiterated	Leerink Partners	Outperform
Aug-07-14	Initiated	Noble Financial	Buy

View All

Heron Therapeutics Inc Stock (HRTX) Latest News

Dec 06, 2025

Activity Recap: Will Heron Therapeutics Inc stock deliver long term returnsDividend Hike & Weekly Market Pulse Updates - BỘ NỘI VỤ

Dec 06, 2025

Dec 05, 2025

San Diego Biotech Firm Heron Therapeutics Shifts Operations to North Carolina - MSN

Dec 05, 2025

What analysts say about Heron Therapeutics Inc stockGrowth Stock Opportunities & 5 Stocks Every Investor Should Own - earlytimes.in

Dec 05, 2025

Market Sentiment Around Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) - simplywall.st

Dec 05, 2025

Dec 04, 2025

Can Heron Therapeutics Inc. stock sustain institutional interestMarket Trend Report & High Return Trade Guides - Newser

Dec 04, 2025

Can Heron Therapeutics Inc. (AXD2) stock expand revenue streamsWeekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser

Dec 04, 2025

How cyclical is Heron Therapeutics Inc. (AXD2) stock compared to rivalsJuly 2025 Setups & Fast Entry High Yield Tips - Newser

Dec 04, 2025

Heron Therapeutics announces inclusion of Aponvie (aprepitant) - marketscreener.com

Dec 04, 2025

Heron Therapeutics (Nasdaq: HRTX) APONVIE cited in fifth consensus PONV care guidelines - Stock Titan

Dec 04, 2025

Why Heron Therapeutics Inc. stock attracts high net worth investorsWeekly Profit Report & Detailed Earnings Play Strategies - Newser

Dec 04, 2025

Dec 03, 2025

Heron Therapeutics Injects New Life Into Growth Story With ZYNRELEF And APONVIE Momentum - RTTNews

Dec 03, 2025

Will Heron Therapeutics Inc. stock deliver long term returnsCPI Data & Risk Controlled Swing Trade Alerts - Newser

Dec 03, 2025

Dec 02, 2025

History Review: Can Heron Therapeutics Inc. stock sustain market leadershipJuly 2025 WrapUp & Daily Profit Focused Screening - BỘ NỘI VỤ

Dec 02, 2025

Dec 01, 2025

Heron Therapeutics (HRTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025

What the Latest News Means for Eurotex Industries and Exports Limited Stock InvestorsProtective Put Strategies & Small Capital Trading Growth - earlytimes.in

Dec 01, 2025

Nov 30, 2025

What analysts say about Heron Therapeutics Inc AXD2 stockMarket Sentiment Surveys & Build a Dividend-Powered Portfolio - earlytimes.in

Nov 30, 2025

Is Heron Therapeutics Inc. stock gaining market sharePortfolio Gains Summary & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ

Nov 30, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Nov 30, 2025

With Heron Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis

Nov 30, 2025

Nov 29, 2025

Trading Action: Can Heron Therapeutics Inc. stock surprise with earnings upsideQuarterly Trade Report & High Accuracy Swing Entry Alerts - BỘ NỘI VỤ

Nov 29, 2025